O

Oxalo Therapeutics, Inc.

2 employees

Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Clinical Trials

Date founded

2017

Funding rounds raised

Total raised

$2.3M

from 1 investors over 1 rounds

O

Oxalo Therapeutics, Inc. raised $2.3M on September 24, 2018

Investors: National Institutes of Health

FAQ